The leading representative office of defined Corporate Investor is situated in the Upper Saddle River. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Sabby Capital, startups are often financed by Third Rock Ventures, New Enterprise Associates, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, Perceptive Advisors, Rock Springs Capital. In the next rounds fund is usually obtained by Perceptive Advisors, Pontifax, Commercial Street Capital.
Among the most popular fund investment industries, there are Biopharma, Therapeutics. Among the various public portfolio startups of the fund, we may underline Epic Sciences, Arno Therapeutics, Stem Cell Therapeutics The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2014. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2015. This Sabby Capital works on 63 percentage points more the average amount of lead investments comparing to the other organizations.
We also calculated 1 valuable employee in our database.
Related Funds
Funds with similar focus
Fund Name | Location |
Alectra | Canada, Mississauga, Ontario |
Apsara Investments | Central, Central Region, Singapore |
Broadhaven Capital Partners | New York, New York, United States |
Godavari Biorefineries | India, Maharashtra, Mumbai |
Hack VC | California, San Francisco, United States |
Hengxu Capital | - |
Jumpstart-up | - |
Leap Wireless | California, San Diego, United States |
Mission Throttle | Michigan, Southfield, United States |
Moscar Capital | England, London, United Kingdom |
National Foundation | - |
Pegasus Capital | Connecticut, Cos Cob, United States |
River Hollow Partners | New York, New York, United States |
RPR Venture | - |
SARVA | India, Maharashtra, Mumbai |
Seek Ventures | England, London, United Kingdom |
Siebel Systems | California, Redwood Shores, United States |
Thuasne | - |
Yingxue Ziben | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Cidara Therapeutics | $42M | 11 Feb 2015 | San Diego, California, United States | ||
Global Blood Therapeutics | $48M | 06 Jan 2015 | San Francisco, California, United States | ||
Naurex | $80M | 03 Dec 2014 | Illinois, United States | ||
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Bellicum Pharmaceuticals | $55M | 27 Aug 2014 | Houston, Texas, United States | ||
Dermira | $51M | 19 Aug 2014 | California, United States | ||
Adverum Biotechnologies | $55M | 22 Apr 2014 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Cidara Therapeutics | $42M | 11 Feb 2015 | San Diego, California, United States | ||
Global Blood Therapeutics | $48M | 06 Jan 2015 | San Francisco, California, United States | ||
Naurex | $80M | 03 Dec 2014 | Illinois, United States | ||
Blueprint Medicines | $50M | 12 Nov 2014 | Cambridge, Massachusetts, United States | ||
Bellicum Pharmaceuticals | $55M | 27 Aug 2014 | Houston, Texas, United States | ||
Dermira | $51M | 19 Aug 2014 | California, United States | ||
Adverum Biotechnologies | $55M | 22 Apr 2014 | California, United States |